Reviva Pharmaceuticals Holdings, Inc.
RVPH· OTC
RVPHReviva Pharmaceuticals Holdings, Inc.
Filed Nov 14, 2023 · 10-Q · 45 days after period end · 0001437749-23-031973
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2019 |
|---|---|---|---|---|
| Net Income | -$10.49M | -$3.52M | -$2.28M | $136.81K |
| EPS Diluted | — | — | -$0.12 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reviva Pharmaceuticals Holdings, Inc. · CIK 1742927 · Engraved from SEC EDGAR
ended Sep 30, 2023 · filed Nov 14, 2023 · 45 d after period end
